Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trial.
Zhu YC, Wei ZG, Wang JJ, Pei YY, Jin J, Li D, Li ZH, Liu ZR, Min Y, Li RD, Yang L, Liu JY, Wei Q, Peng XC.
Zhu YC, et al. Among authors: pei yy.
Nat Commun. 2024 Nov 29;15(1):10371. doi: 10.1038/s41467-024-54661-9.
Nat Commun. 2024.
PMID: 39609453
Free PMC article.
Clinical Trial.